Electrosurgery

(redirected from Bovie)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

electrosurgery

[i¦lek·trō′sərj·ə·rē]
(medicine)
The use of electricity to perform surgical procedures, as the use of electricity to simultaneously cut tissue and arrest bleeding.

Electrosurgery

 

surgery involving the application of a high-frequency current (hundreds of thousands of oscillations per second) to tissues, with a sharp elevation of temperature at the point of contact between the active electrode and the tissues.

A distinction is made between electrotomy, the separation and excision of tissues, and electrocoagulation, the cauterization (coagulation of proteins) of tissues. Incision of tissues with an electric knife does not cause bleeding because the blood coagulates along the incision. Electrosurgical methods are used in operations on the brain (the bloodless operative field permits visual control of the operation) and eyes. They are also used to remove skin tumors and in dentistry.

References in periodicals archive ?
Andrew Makrides, chief executive officer of Bovie Medical, stated, "Both new and longstanding OEM customer sales increases positively impacted on first quarter revenues.
The agreement also includes Bovie exclusively distributing Medical Illumination's non-LED medical lights as well as any new LED lights under development.
Additionally, Bovie announced a joint venture with a major
CONTACT: Bovie Medical Corporation Andrew Makrides, President 800/888-4999
Bovie Medical Corporation ("Bovie" or the "Company") (NYSE Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced that it has been served with a summons and complaint in a stockholders derivative action that has been filed by two purported stockholders against the Company, several officers, directors and one former director.
SAN DIEGO -- Robbins Umeda LLP, a shareholder rights litigation firm, has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by certain officers and directors at Bovie Medical Corporation (AMEX: BVX).
Smith announces that it is investigating potential claims against Bovie Medical Corporation ("Bovie" or the "Company") (NYSE Amex:BVX) concerning possible breaches of fiduciary duties by the Company or its fiduciaries.
Bovie has also received initial orders resulting from its exclusive distribution agreement for the sale of a new next-generation medical lighting product entry.
Bovie Medical Corporation (the "Company") (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced that the Company has received initial orders for J-Plasma[TM] and has been granted its fifth patent for the product.
Bovie Medical Corporation (the "Company") (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products and its new J-Plasma[TM] system, today announced that the Company will present at the 2012 SeeThru Equity Fall Smallcap and Microcap Conference Tuesday, October 2, 2012 at 11:20am ET, at The Cornell Club 6 East 44th Street New York City, New York.
April 1, 2013 /PRNewswire/ -- Bovie Medical Corporation (the "Company")(NYSE Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced its financial results for the year ended December 31, 2012 and fourth quarter.